Company Analysis Intuitive Surgical
1. Summary
Advantages
- The stock's return over the last year (66.82%) is higher than the sector average (-19.51%).
- The company's current efficiency (ROE=13.51%) is higher than the sector average (ROE=9.61%)
Disadvantages
- Price (278.5 $) is higher than fair price (57.94 $)
- Dividends (0%) are below the sector average (0.5468%).
- Current debt level 0.5815% has increased over 5 years from 0%.
Similar companies
2. Share price and performance
2.1. Share price
2.2. News
2.3. Market efficiency
| Intuitive Surgical | Healthcare | Index | |
|---|---|---|---|
| 7 days | -0.1% | -12.7% | -1.3% |
| 90 days | 12.6% | -27.8% | 9.3% |
| 1 year | 66.8% | -19.5% | 31.8% |
ISRG vs Sector: Intuitive Surgical has outperformed the "Healthcare" sector by 86.33% over the past year.
ISRG vs Market: Intuitive Surgical has outperformed the market by 34.97% over the past year.
Stable price: ISRG is not significantly more volatile than the rest of the market on "NASDAQ" over the last 3 months, with typical variations of +/- 5% per week.
Long period: ISRG with weekly volatility of 1.28% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (278.5 $) is higher than the fair price (57.94 $).
Price is higher than fair: The current price (278.5 $) is 79.2% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (66.84) is higher than that of the sector as a whole (48.77).
P/E vs Market: The company's P/E (66.84) is higher than that of the market as a whole (48.89).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (8.97) is higher than that of the sector as a whole (4.82).
P/BV vs Market: The company's P/BV (8.97) is higher than that of the market as a whole (3.36).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (16.87) is lower than that of the sector as a whole (33.76).
P/S vs Market: The company's P/S indicator (16.87) is higher than that of the market as a whole (10.23).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (53.7) is higher than that of the sector as a whole (-22.15).
EV/Ebitda vs Market: The company's EV/Ebitda (53.7) is higher than that of the market as a whole (28.27).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Rising and has grown by 6.06% over the last 5 years.
Earnings Slowdown: The last year's return (0%) is below the 5-year average return (6.06%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-9.16%).
5.4. ROE
ROE vs Sector: The company's ROE (13.51%) is higher than that of the sector as a whole (9.61%).
ROE vs Market: The company's ROE (13.51%) is higher than that of the market as a whole (10.79%).
5.5. ROA
ROA vs Sector: The company's ROA (11.64%) is higher than that of the sector as a whole (0.3443%).
ROA vs Market: The company's ROA (11.64%) is higher than that of the market as a whole (6.51%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (14.77%) is higher than that of the sector as a whole (7.63%).
ROIC vs Market: The company's ROIC (14.77%) is higher than that of the market as a whole (10.79%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '0.5468%.
7.2. Stability and increase in payments
Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.
8. Insider trades
8.1. Insider trading
Insider Buying Exceeds insider sales by 33.18% over the last 3 months.
8.2. Latest transactions
| Transaction date | Insider | Type | Price | Volume | Quantity |
|---|---|---|---|---|---|
| 29.10.2024 | ROBERT DESANTIS Officer |
Purchase | 506.52 | 95 226 | 188 |
| 28.10.2024 | ROBERT DESANTIS Officer |
Purchase | 513.66 | 299 977 | 584 |
| 28.10.2024 | MARK BROSIUS Officer |
Purchase | 513.66 | 11 301 | 22 |
| 25.10.2024 | ROBERT DESANTIS Officer |
Purchase | 514 | 520 168 | 1 012 |
| 25.10.2024 | MARK BROSIUS Officer |
Purchase | 514 | 11 308 | 22 |
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
